Reports

Ideas That Generate Results

List of Figures:

Figure 3-1: Healthcare Spending (US$ per head), 2015-2020
Figure 3-2: Consumer Healthcare Spending (Billion US$), 2015-2020
Figure 3-3: Share of Diagnostic Services in Total Healthcare Expenditure (%), 2015
Figure 3-4: Share of Public and Private Hospitals in Total Hospitals (%), 2015
Figure 3-5: Population (Million), 2015-2020
Figure 3-6: Population Breakup by Urban and Rural India (%), 2015
Figure 3-7: Middle Class Population (Million), 2015-2020
Figure 6-1: Share of Pathology and Radiology in Diagnostic Services Market (%), 2015
Figure 6-2: Share of Organized Diagnostic Services Market (%), 2015
Figure 6-3: Share of Organized Diagnostic Services Market (%), 2020
Figure 6-4: Diagnostic Services Market (Billion INR), 2015-2020
Figure 6-5: Pathology Services Market (Billion INR), 2015-2020
Figure 6-6: Share of Organized Pathology Services Market (%), 2020
Figure 6-7: Pathology Services Market by Segments (%), 2015
Figure 6-8: Radiology Services Market (Billion INR), 2015-2020
Figure 6-9: Share of Organized Radiology Services Market (%), 2020
Figure 6-10: Radiology Services Market by Segment (2015)
Figure 7-1: Percentage Breakup of Diagnostic Labs in Urban and Rural India
Figure 7-2: PE Investment in Key Sectors of Healthcare and Life Sciences (%), 2015
Figure 7-3: PE Investment (Million US$) and Number of Deals in Diagnostics, FY 2011-FY 2015
Figure 9-1: Tier-Wise Diagnostic Test Expenditure/Year
Figure 9-2: Consumer Preference for Physician Prescribed Lab
Figure 9-3: Factors Impacting Consumer Lab Preference
Figure 9-4: Consumer Preference by Lab Type (Independent/Hospital)
Figure 9-5: Consumer Preference by Lab Type (Government/Private)
Figure 9-6: Consumer Preference by Lab Type (Small/Medium/Large)
Figure 10-1: Flowchart for NABL Accreditation Procedure
Figure 11-1: Dr. Lal Path Labs - Breakup of Revenue by Region (%), 2015

List of Tables:

Table 3-1: Population Break-up by Age-Group (Million), 2015-2020
Table 5-1: Prevalence of Cancer (Million), 2013-2015
Table 5-2: Prevalence & Incidences of Tuberculosis (Million), 2013-2015
Table 5-3: Incidence of Malaria (Million), 2013-2015
Table 5-4: Prevalence of HIV/AIDS (Million), 2013-2015
Table 5-5: Prevalence of Diabetes (Million), 2013-2015
Table 5-6: Incidence of Dengue, 2013-2015
Table 7-1: Distribution of Diagnostic Labs in Urban Area (Class I to VI)
Table 7-2: Investigation Cost of Common Biochemical Tests in Tier I and Tier II (INR)
Table 7-3: Investigation Cost of Common Hematology Tests in Tier I and Tier II (INR)
Table 7-4: Investigation Cost of Common Immunology Tests in Tier I and Tier II (INR)
Table 7-5: Investigation Cost of Common Urinology Tests in Tier I and Tier II (INR)
Table 7-6: Investigation Cost of Common Coagulation Tests in Tier I and Tier II (INR)
Table 7-7: Investigation Cost of Common X-Ray Tests in Tier I and Tier II (INR)
Table 7-8: Investigation Cost of Common Ultrasound Tests in Tier I and Tier II (INR)
Table 7-9: Investigation Cost of Common MRI Tests in Tier I and Tier II (INR)
Table 7-10: Investigation Cost of Common CT Tests in Tier I and Tier II (INR)
Table 7-11: Investigation Cost of Common PET-CT Test in Tier I and Tier II (INR)
Table 8-1: Role of Key Stakeholders in Healthcare PPP Model
Table 8-2: Key Healthcare PPP Projects
Table 8-3: Key Diagnostic Services PPP Projects
Table 8-4: Advantages of Single Specialty Model in Diagnostic Services
Table 9-1: Characteristics of Sample Surveyed
Table 11-1: Dr. Lal Path Labs - Key Financials (Million INR), 2013-2015
Table 11-2: Quest Diagnostics - Key G2Financials (Million INR), 2013-2015